Mereo BioPharma Group (MREO) stock

Worth $238MShares as of Nov 9

$0.30

+0.95%

As of Tuesday's close · Live for Pro members at the open

Not scored

Breakaway doesn't score MREO. It is too small and priced too low for a fair Quality Score.

Healthcare · Biotech

NextEarly 2027“…streamline the Phase 3 design and are working to be in a position to initiate the Phase 3 study in early 2027…”Trial start · SEC filing · Nov 9

Cash$26.1M, about 4 quarters at the last year's spendingOn Sep 30 · the company says “into late-2027”

Follow MREO's news. Pro members can get an alert when Mereo BioPharma Group files news, and see its trials, share raises, and its CEO's filings.

Get an alert when MREO files newsSee it live, free until Thursday morning. No account. No card. Then keep going with a free account.

We do the work for you. 3,168 stocks are scored and ranked, every 15 seconds while the market is open. Pro members see it live.

Cash$26.1M, about 4 quarters at the last year's spendingOn Sep 30 · the company says “into late-2027”

What's next for MREO, and how long its cash lasts

Next step the company has named

Early 2027“…interactions on alvelestat for AATD-LD alongside Sentynl Therapeutics to streamline the Phase 3 design and are working to be in a position to initiate the Phase 3 study in early 2027.”Trial start · SEC filing · Nov 9

What it means: when a trial begins, or reaches the stage the company named.

Lead program: Alvelestat

For Pro members: 1 more milestone and 31 filings.

Cash runway Sep 30 balance sheet

About 4 quarters

$26.1M in cash and short-term investments, at its spending over the last year

What it means: how long the cash would last at the same pace, before any new money. The company's estimate is “into late-2027” (8-K, Nov 9).

For Pro members: the cash used each quarter, and the math.

Dilution on the horizon

Shelf registration (S-3, filed May 15, 2024)
At-the-market share sales program (S-3, filed May 15, 2024)

For Pro members: 1 raise and its amount, and the share count against a year ago.

Insiders

No open-market buys or sales by its officers or directors in their filings of the last year.

From Form 4: open-market buys and sales only.

Get an alert when Denise Scots-Knight buys or sells

For Pro members: every trade, and Denise Scots-Knight’s 11 filings and quotes.

Get an alert when MREO files newsA free account. No card.

See every upcoming FDA date →

FDA dates in the next 60 days

Decision dates and advisory committee meetings the companies have announced in their filings, soonest first and small companies first.

DateStockDrug

In 12 daysFDA decisionIn 12 days · FDA decisionCAPRCapricor TherapeuticsDeramiocelCAPRCapricor Therapeutics · $500MDeramiocelFDA decision due (PDUFA)
In 12 daysFDA decisionIn 12 days · FDA decisionSVRASavaraMolgramostimSVRASavara · $900MMolgramostimFDA decision due (PDUFA)
In 42 daysFDA decisionIn 42 days · FDA decisionMLYSMineralys TherapeuticsLorundrostatMLYSMineralys Therapeutics · $1.3BLorundrostatFDA decision due (PDUFA)

14 more FDA dates and 103 trial data dates in the next 60 days, each on the FDA calendar. Pro members see whether each company's cash lasts past its date, with an optional alert before it. See all 151 dates, ranked →

MREO's latest filings

Quarterly report10-Q, filed Nov 9
Mereo BioPharma Reports Third Quarter 2026 Financial Results Ongoing regulatory interactions in collaboration with Ultragenyx on potential path forward for setrusumab in osteogenesis imperfecta (OI)8-K, filed Nov 9
8 insider filingsForm 4, filed Feb 27

16 more filings in the last year, for Pro members

From SEC EDGAR, as filed. Each opens the filing on the SEC's site.

Why MREO isn't scored

The Quality Score reads US-listed stocks worth $50M or more that trade at $1 or more and 300,000 shares or $10M a day. MREO is worth about $238M and trades at $0.30. A stock that clears every mark is scored from the next weekly rebuild.

Straight AnswersStraight Answers

Are the prices delayed?

Only on the public pages, which run at least 15 minutes behind. Pro members, and anyone on a guest pass, see real-time prices: the scanner refreshes every 15 seconds, and your watchlist every few seconds, pre-market and after hours included.